ORIC — ORIC PHARMACEUTICALS INC COM

Ownership history in US BANCORP \DE\  ·  6 quarters on record

This page tracks every 13F SEC filing in which US BANCORP \DE\ reported a position in ORIC PHARMACEUTICALS INC COM (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 34 +6 +21.4% 0.00% $408 $12.00
2025 Q2 ADDED 28 +6 +27.3% 0.00% $284 $10.15
2025 Q1 REDUCED 22 -5 -18.5% 0.00% $123 $5.58
2024 Q4 REDUCED 27 -985 -97.3% 0.00% $218 $8.07
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ORIC price (monthly, adj. close)

Other funds also holding ORIC

As of 2025 Q4 — sorted by position size

Column Group LLC 3Y 34.98% PFIZER INC 18.6% SR ONE CAPITAL MANAGEMENT, LP 3Y 5.34% EcoR1 Capital, LLC 3Y 7Y 2.5% VR Adviser, LLC 3Y 2.29% Euclidean Capital LLC 3Y 2.19% First Turn Management, LLC 1.88% NEA Management Company, LLC 3Y 7Y 1.72% MPM BioImpact LLC 3Y 1.68% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.59%
← Back to US BANCORP \DE\ Holdings